CN104705756A - 有益菌胶原蛋白饮料 - Google Patents
有益菌胶原蛋白饮料 Download PDFInfo
- Publication number
- CN104705756A CN104705756A CN201510078930.3A CN201510078930A CN104705756A CN 104705756 A CN104705756 A CN 104705756A CN 201510078930 A CN201510078930 A CN 201510078930A CN 104705756 A CN104705756 A CN 104705756A
- Authority
- CN
- China
- Prior art keywords
- collagen
- beneficial bacterium
- beverage
- pure water
- streptococcus thermophilus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 61
- 108010035532 Collagen Proteins 0.000 title claims abstract description 61
- 229920001436 collagen Polymers 0.000 title claims abstract description 61
- 241000894006 Bacteria Species 0.000 title claims abstract description 35
- 235000013361 beverage Nutrition 0.000 title claims abstract description 32
- 230000009286 beneficial effect Effects 0.000 title claims abstract description 29
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000011575 calcium Substances 0.000 claims abstract description 28
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims abstract description 21
- 241000186672 Lactobacillus delbrueckii subsp. bulgaricus Species 0.000 claims abstract description 21
- 241000194020 Streptococcus thermophilus Species 0.000 claims abstract description 21
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims abstract description 21
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims abstract description 21
- 238000003756 stirring Methods 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 10
- 238000010521 absorption reaction Methods 0.000 abstract description 6
- 229910052742 iron Inorganic materials 0.000 abstract description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 229910052698 phosphorus Inorganic materials 0.000 abstract description 3
- 239000011574 phosphorus Substances 0.000 abstract description 3
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 abstract description 2
- 108010012715 Superoxide dismutase Proteins 0.000 abstract description 2
- 229930003451 Vitamin B1 Natural products 0.000 abstract description 2
- 229930003471 Vitamin B2 Natural products 0.000 abstract description 2
- 230000036772 blood pressure Effects 0.000 abstract description 2
- 229910001424 calcium ion Inorganic materials 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract description 2
- 229960002477 riboflavin Drugs 0.000 abstract description 2
- 229960003495 thiamine Drugs 0.000 abstract description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract description 2
- 235000010374 vitamin B1 Nutrition 0.000 abstract description 2
- 239000011691 vitamin B1 Substances 0.000 abstract description 2
- 235000019164 vitamin B2 Nutrition 0.000 abstract description 2
- 239000011716 vitamin B2 Substances 0.000 abstract description 2
- 235000019158 vitamin B6 Nutrition 0.000 abstract description 2
- 239000011726 vitamin B6 Substances 0.000 abstract description 2
- 229940011671 vitamin b6 Drugs 0.000 abstract description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 abstract 1
- 210000000750 endocrine system Anatomy 0.000 abstract 1
- 230000009758 senescence Effects 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 235000012000 cholesterol Nutrition 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 102000005606 Activins Human genes 0.000 description 2
- 108010059616 Activins Proteins 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000488 activin Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 201000000839 Vitamin K Deficiency Bleeding Diseases 0.000 description 1
- 206010047634 Vitamin K deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 208000037849 arterial hypertension Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 208000015294 blood coagulation disease Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 208000016794 vitamin K deficiency hemorrhagic disease Diseases 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/123—Bulgaricus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明属于饮料技术领域，涉及一种有益菌胶原蛋白饮料；包括鳕鱼皮胶原蛋白、低聚木糖、保加利亚乳杆菌、嗜热链球菌、生物活性钙和纯净水，各组分的重量分数比为：鳕鱼皮胶原蛋白：3.3％-11.6％，低聚木糖0.7％-1.5％，保加利亚乳杆菌0.7％-1.2％，嗜热链球菌0.5％-1％，生物活性钙1.5％-3％，纯净水85％-90％；能够改善胃肠功能，促进维生素B1、B2、B6及人体对钙离子的吸收，进而双向调节人体机能及内分泌系统，改善睡眠，激活人体免疫力；提高钙、磷、铁和胶原蛋白的利用率，调节血压，产生超氧化物歧化酶，清除体内代谢过程中产生的过量超氧阴离子自由基，延缓衰老。
Description
技术领域
本发明属于饮料技术领域，具体地说，涉及一种有益菌胶原蛋白饮料。
背景技术
胶原蛋白属于生物高分子，是动物结缔组织中的主要成分，也是哺乳动物体内含量最多、分布最广的功能性蛋白，占蛋白质总量的25％～30％,与组织的形成、成熟、细胞间信息的传递，以及关节润滑、伤口愈合、钙化作用、血液凝固和衰老等有着密切的关系。由于宗教信仰和人们对疯牛病、口蹄疫等疾病的恐慌，以及猪或牛为原料制备的胶原蛋白在发展应用上受到一定的限制，而鳕鱼皮胶原蛋白可以避免这些弊端。鳕鱼皮胶原蛋白含有丰富的营养成分，消化吸收率高，且度具有保湿型，能是肌肤盈润、光洁、富有弹性。同时可以促进钙的吸收。
胶原蛋白是皮肤的主要成分，占皮肤干重的70—80％。胶原蛋白在皮肤中锁住水分，支撑着皮肤，胶原蛋白的流失会导致皮肤组织萎缩，出现肌肤干燥、皱纹、色斑、毛孔粗大等一系列问题。胶原蛋白也能降低血甘油三酯和胆固醇，增强体内必须微量元素的吸收，从而使其维持在一个相对正常的范围之内，能够减肥降血脂。胶原蛋白能使血管正常运作，预防动脉硬化和高血压，是适合糖尿病、肾脏病患等重症患者摄取优质高蛋白保健食品。
在人的肠道里保持较多数量的有益菌群，有利于维持身体健康，能够降低胆固醇和血脂，有益菌能降低抑制胆固醇的合成，阻止人体对胆固醇的吸收、利用等。有益菌群在肠道中合成部分维生素，尤其是维生素K，在食物中含量非常少，有益菌群的减少，将会导致维生素K缺乏症，产生腹泻和凝血障碍性疾病等。促进钙、铁、维生素D的吸收，乳酸杆菌在代谢过程中会产生大量的酸，酸会提高钙的可溶性，并直接刺激胃肠道最大限度地吸收钙、铁、锌等。抗癌益生菌能降解亚硝胺，消除亚硝胺的致癌性，而且促进肠道蠕动，蠕动加快后，这些有害菌就随着粪便排出人体。
因此，本发明的有益菌胶原蛋白饮料对有效补充体内流失的胶原蛋白是十分重要的。
发明内容
本发明的目的在于克服现有技术存在的缺点，寻求设计一种能够提高钙、磷、铁和胶原蛋白的利用率，延缓衰老，激活人体免疫力的有益菌胶原蛋白。
为了实现上述目的，本发明采用的技术方案为：一种有益菌胶原蛋白饮料，包括鳕鱼皮胶原蛋白、低聚木糖、保加利亚乳杆菌、嗜热链球菌、生物活性钙和纯净水，各组分的重量分数比为：
鳕鱼皮胶原蛋白：3.3％-11.6％
低聚木糖0.7％-1.5％
保加利亚乳杆菌0.7％-1.2％
嗜热链球菌0.5％-1％
生物活性钙1.5％-3％
纯净水85％-90％。
有益菌胶原蛋白饮料的制备工艺为：按重量分数比称取各组分，将鳕鱼皮胶原蛋白、低聚木糖和生物活性钙加入搅拌缸，加入纯净水调配搅拌10分钟；后在90±5℃的温度下杀菌10-60秒；将杀完菌的饮料冷却至40-45℃，然后加入保加利亚乳杆菌、嗜热链球菌，再次搅拌10分钟，得到有益菌胶原蛋白饮料。
本发明的有益效果为：能够改善胃肠功能，促进维生素B1、B2、B6及人体对钙离子的吸收，进而双向调节人体机能及内分泌系统，改善睡眠，激活人体免疫力；能够促进消化吸收，减少有害物质在体内滞留，抑制致癌物质的产生；提高钙、磷、铁和胶原蛋白的利用率，调节血压，同时能产生超氧化物歧化酶，能够清除体内代谢过程中产生的过量超氧阴离子自由基，延缓衰老。
具体实施方式
下面通过具体实施例对本发明作进一步描述：
实施例1
本实施例的有益菌胶原蛋白饮料，包括鳕鱼皮胶原蛋白、低聚木糖、保加利亚乳杆菌、嗜热链球菌、生物活性钙和纯净水，各组分的重量分数比为：
鳕鱼皮胶原蛋白：4.6％，低聚木糖0.7％，保加利亚乳杆菌0.7％，嗜热链球菌1％，生物活性钙3％，纯净水90％。
本实施例的有益菌胶原蛋白制备工艺为：按重量分数比称取各组分，将鳕鱼皮胶原蛋白、低聚木糖和生物活性钙加入搅拌缸，加入纯净水调配搅拌10分钟；后在90±5℃的温度下杀菌10秒；将杀完菌的饮料冷却至40℃，然后加入保加利亚乳杆菌、嗜热链球菌，再次搅拌10分钟，得到有益菌胶原蛋白饮料。
实施例2
本实施例的有益菌胶原蛋白饮料，包括鳕鱼皮胶原蛋白、低聚木糖、保加利亚乳杆菌、嗜热链球菌、生物活性钙和纯净水，各组分的重量分数比为：
鳕鱼皮胶原蛋白：3.3％，低聚木糖1.5％，保加利亚乳杆菌1.2％，嗜热链球菌1％，生物活性钙3％，纯净水90％。
本实施例的有益菌胶原蛋白制备工艺为：按重量分数比称取各组分，将鳕鱼皮胶原蛋白、低聚木糖和生物活性钙加入搅拌缸，加入纯净水调配搅拌10分钟；后在90±5℃的温度下杀菌60秒；将杀完菌的饮料冷却至45℃，然后加入保加利亚乳杆菌、嗜热链球菌，再次搅拌10分钟，得到有益菌胶原蛋白饮料。
实施例3
本实施例的有益菌胶原蛋白饮料，包括鳕鱼皮胶原蛋白、低聚木糖、保加利亚乳杆菌、嗜热链球菌、生物活性钙和纯净水，各组分的重量分数比为：
鳕鱼皮胶原蛋白：8％，低聚木糖1％，保加利亚乳杆菌1％，嗜热链球菌0.8％，生物活性钙2％，纯净水87.2％。
本实施例的有益菌胶原蛋白饮料的制备工艺为：按重量分数比称取各组分，将鳕鱼皮胶原蛋白、低聚木糖和生物活性钙加入搅拌缸，加入纯净水调配搅拌10分钟；后在90±5℃的温度下杀菌20秒；将杀完菌的饮料冷却至42℃，然后加入保加利亚乳杆菌、嗜热链球菌，再次搅拌10分钟，得到有益菌胶原蛋白饮料。
实施例4
本实施例的有益菌胶原蛋白饮料，包括鳕鱼皮胶原蛋白、低聚木糖、保加利亚乳杆菌、嗜热链球菌、生物活性钙和纯净水，各组分的重量分数比为：
鳕鱼皮胶原蛋白：8.7％，低聚木糖1.2％，保加利亚乳杆菌0.9％，嗜热链球菌0.7％，生物活性钙2.5％，纯净水86％。
本实施例的有益菌胶原蛋白饮料的制备工艺为：按重量分数比称取各组分，将鳕鱼皮胶原蛋白、低聚木糖和生物活性钙加入搅拌缸，加入纯净水调配搅拌10分钟；后在90±5℃的温度下杀菌40秒；将杀完菌的饮料冷却至43℃，然后加入保加利亚乳杆菌、嗜热链球菌，再次搅拌10分钟，得到有益菌胶原蛋白饮料。
实施例5
本实施例的有益菌胶原蛋白饮料，包括鳕鱼皮胶原蛋白、低聚木糖、保加利亚乳杆菌、嗜热链球菌、生物活性钙和纯净水，各组分的重量分数比为：
鳕鱼皮胶原蛋白：10.3％，低聚木糖1.5％，保加利亚乳杆菌0.7％，嗜热链球菌1％，生物活性钙1.5％，纯净水85％。
其它同实施例1。
Claims (2)
1.一种有益菌胶原蛋白饮料，其特征在于：包括鳕鱼皮胶原蛋白、低聚木糖、保加利亚乳杆菌、嗜热链球菌、生物活性钙和纯净水，各组分的重量分数比为：
鳕鱼皮胶原蛋白：3.3％-11.6％
低聚木糖 0.7％-1.5％
保加利亚乳杆菌 0.7％-1.2％
嗜热链球菌 0.5％-1％
生物活性钙 1.5％-3％
纯净水 85％-90％。
2.根据权利要求1所述的有益菌胶原蛋白饮料的制备工艺为：按重量分数比称取各组分，将鳕鱼皮胶原蛋白、低聚木糖和生物活性钙加入搅拌缸，加入纯净水调配搅拌10分钟；后在90±5℃的温度下杀菌10-60秒；将杀完菌的饮料冷却至40-45℃，然后加入保加利亚乳杆菌、嗜热链球菌，再次搅拌10分钟，得到有益菌胶原蛋白饮料。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510078930.3A CN104705756B (zh) | 2015-02-12 | 2015-02-12 | 有益菌胶原蛋白饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510078930.3A CN104705756B (zh) | 2015-02-12 | 2015-02-12 | 有益菌胶原蛋白饮料 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104705756A true CN104705756A (zh) | 2015-06-17 |
| CN104705756B CN104705756B (zh) | 2016-08-24 |
Family
ID=53405855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510078930.3A Expired - Fee Related CN104705756B (zh) | 2015-02-12 | 2015-02-12 | 有益菌胶原蛋白饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104705756B (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110613070A (zh) * | 2019-10-18 | 2019-12-27 | 汕尾市维明生物科技股份有限公司 | 一种胶原蛋白饮料及其制备方法 |
| CN116508922A (zh) * | 2023-05-21 | 2023-08-01 | 江西蒙天乳业有限公司 | 一种常温乳酸菌的制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007099625A (ja) * | 2005-09-30 | 2007-04-19 | Ryukyu Bio Resource Kaihatsu:Kk | 皮膚線維芽細胞増殖促進剤 |
| CN101099861A (zh) * | 2007-07-25 | 2008-01-09 | 上海交大昂立股份有限公司 | 一种含嗜酸乳杆菌的组合物及其应用 |
| CN103340399A (zh) * | 2013-06-18 | 2013-10-09 | 哈尔滨天鹅土畜产技术开发公司 | 一种制备骨胶原蛋白乳酸菌玫瑰口服液的方法 |
-
2015
- 2015-02-12 CN CN201510078930.3A patent/CN104705756B/zh not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007099625A (ja) * | 2005-09-30 | 2007-04-19 | Ryukyu Bio Resource Kaihatsu:Kk | 皮膚線維芽細胞増殖促進剤 |
| CN101099861A (zh) * | 2007-07-25 | 2008-01-09 | 上海交大昂立股份有限公司 | 一种含嗜酸乳杆菌的组合物及其应用 |
| CN103340399A (zh) * | 2013-06-18 | 2013-10-09 | 哈尔滨天鹅土畜产技术开发公司 | 一种制备骨胶原蛋白乳酸菌玫瑰口服液的方法 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110613070A (zh) * | 2019-10-18 | 2019-12-27 | 汕尾市维明生物科技股份有限公司 | 一种胶原蛋白饮料及其制备方法 |
| CN116508922A (zh) * | 2023-05-21 | 2023-08-01 | 江西蒙天乳业有限公司 | 一种常温乳酸菌的制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104705756B (zh) | 2016-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111616232A (zh) | 一种促进骨骼生长的儿童奶粉及其制备方法 | |
| Pfeuffer et al. | Nutrition and health aspects of milk and dairy products and their ingredients | |
| CN105494647B (zh) | 一种钙强化乳粉及其制备方法 | |
| Klobukowski et al. | Calcium bioavailability from dairy products and its release from food by in vitro digestion | |
| CN101642165B (zh) | 一种减肥酸奶饮料的制作方法 | |
| CN103462015A (zh) | 一种脂溶性营养物质的包埋保护方法 | |
| CN103690559A (zh) | 补充剂钙镁铁锌的制剂类型及其中口服液制备方法 | |
| CN106165905B (zh) | 一种钙加维生素软胶囊及制备方法 | |
| CN113632851A (zh) | 一种多功能儿童生长奶粉及其制备方法 | |
| CN112655765A (zh) | 一种能延缓衰老、预防心脑血管疾病和糖尿病的奶粉配方 | |
| CN108244659A (zh) | 一种益生元 | |
| CN104705756A (zh) | 有益菌胶原蛋白饮料 | |
| CN103719202A (zh) | 糖尿病脂肪肝食疗饼干 | |
| CN103392800A (zh) | 高钙低脂无蔗糖凝固型酸牛奶及其生产方法 | |
| CN107467193B (zh) | 一种以羊奶为基础的粉剂全营养特殊医学用途配方食品及其制备方法 | |
| Horst-Sikorska et al. | The role of anorexia nervosa in secondary osteoporosis development with the risk for low energy fractures | |
| CN102919374A (zh) | 一种怀山药植物蛋白饮料及其制法 | |
| CN101816334B (zh) | 脱脂脱糖降血糖奶粉及其制备方法 | |
| KR20210111789A (ko) | 포스페이트 결합제와 비타민 k의 조합 요법 | |
| CN101224005A (zh) | 一种具有全营养补充功效的营养片剂及其生产方法 | |
| JP2008017815A (ja) | 抗更年期障害食品 | |
| CN103380819A (zh) | 一种高营养乳酸菌保健饮料 | |
| CN104432335A (zh) | 野生蓝莓黑木耳蜂蜜混合果汁饮料及其制备方法 | |
| CN103120308A (zh) | 一种营养方便食品及其制备方法 | |
| CN108157510A (zh) | 一种玉木耳酸奶及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20170215 Granted publication date: 20160824 |
|
| RINS | Preservation of patent right or utility model and its discharge | ||
| PD01 | Discharge of preservation of patent | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20170815 Granted publication date: 20160824 |
|
| PP01 | Preservation of patent right | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20171016 Granted publication date: 20160824 |
|
| PD01 | Discharge of preservation of patent | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20191016 Granted publication date: 20160824 |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160824 Termination date: 20180212 |